title: Hyper-CVAD in mantle-cell lymphoma: really "hyper" or just hype?
authors.affiliation: Department of Medicine III, University of Munich-Campus, Grosshadern, Germany. martin.dreyling@med.uni-muenchen.de
authors.forename: Martin
authors.initials: M
authors.lastname: Dreyling
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D012074:Remission Induction; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide